Screener
Sarepta Therapeutics, Inc. SRPT Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenues: | ||||
| Products, net | $328,689 | $513,123 | $659,204 | $1,124,646 |
| Collaboration and other | 72,562 | 97,968 | 472,850 | 231,301 |
| Total revenues | 401,251 | 611,091 | 1,132,054 | 1,355,947 |
| Cost and expenses: | ||||
| Cost of sales (excluding amortization of in-licensed rights) | 149,385 | 152,558 | 258,153 | 290,122 |
| Research and development | 91,258 | 204,392 | 245,218 | 977,840 |
| Selling, general and administrative | 107,600 | 137,897 | 216,551 | 271,526 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s total revenue?
- Sarepta Therapeutics, Inc. (SRPT) reported total revenue of $401.25M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s total revenue changed year-over-year?
- Sarepta Therapeutics, Inc.'s total revenue decreased by 34.3% year-over-year, from $611.09M to $401.25M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s total revenue?
- Over 3 years (2021 to 2025), Sarepta Therapeutics, Inc.'s total revenue has grown at a 46.3% compound annual growth rate (CAGR), from $701.89M to $2.2B.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Sarepta Therapeutics, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude